| Stage | ALSN | % of rev | NEU | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $717M | 100.00% | ALSN ×2.19 |
| Gross profit | $515M | 32.89% | $222M | 31.03% | ALSN +1.9pp |
| Operating income | $291M | 18.58% | $143M | 19.95% | NEU +1.4pp |
| Pre-tax income | $228M | 14.56% | $151M | 21.10% | NEU +6.5pp |
| Net income | $181M | 11.56% | $124M | 17.32% | NEU +5.8pp |
| Stage | ALSN | NEU | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $717M100.00% | ALSN ×2.19 |
| Gross profit | 32.89%$515M | 31.03%$222M | ALSN +1.9pp |
| Operating income | 18.58%$291M | 19.95%$143M | NEU +1.4pp |
| Pre-tax income | 14.56%$228M | 21.10%$151M | NEU +6.5pp |
| Net income |
| 11.56%$181M |
| 17.32%$124M |
| NEU +5.8pp |
No shared counterparties.